A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo

NCT06804811 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

NonSegmental Vitiligo

Interventions

DRUG: Ruxolitinib Cream
DRUG: Vehicle Cream

Sponsor

Incyte Corporation